Impact of margin thermal ablation after cold-forceps avulsion with snare-tip soft coagulation for nonlifting large...

Nonlifting large nonpedunculated colorectal polyps (NL-LNPCPs) account for 15% of LNPCPs and are effectively managed by endoscopic mucosal resection (EMR) with adjunctive cold-forceps avulsion with adjuvant snare-tip soft coagulation (CAST). Recurrence rates >10% at surveillance colonoscopy are however a significant limitation. We aimed to compare the outcomes of CAST plus margin thermal ablation (MTA) versus CAST alone for NL-LNPCPs.

Prospective observational data on consecutive patients with NL-LNPCPs treated by EMR and CAST at a single tertiary center were retrospectively evaluated. Two cohorts were established: the pre-MTA period (January 2012–June 2017) and the MTA period (July 2017–October 2023). The primary outcome was the residual/recurrent adenoma (RRA) rate at first surveillance colonoscopy (SC1). Secondary outcomes included the RRA rate at SC2 and adverse events.

Over 142 months, 300 patients underwent EMR and CAST for LNPCP: 103 lesions pre-MTA and 197 with MTA. At SC1 and SC2, recurrence was lower in the MTA cohort compared with the pre-MTA cohort (5.0% vs. 18.8% and 0.8% vs. 10.0%, respectively; both P<0.001). Adverse events were similar between the two cohorts for deep mural injury types III–V (pre-MTA 2.9% vs. MTA 5.6%; P=0.29) and delayed bleeding (pre-MTA 8.7% vs. MTA 7.1%; P=0.49). On multivariate analysis, MTA was the only variable independently associated with a reduced likelihood of recurrence (odds ratio 0.20, 95%CI 0.07–0.54; P=0.001).

For NL-LNPCPs, MTA in combination with CAST is safe and effective and reduces recurrence at SC1 in comparison with CAST alone.